| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.005 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.005 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.005 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.007 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.007 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.007 |